Dynamic changes of systemic inflammatory markers and their association with radiologic progression and hepatotoxicity in patients with hepatocellular carcinoma on systemic therapy - Egyptian Knowledge Bank

417919

Dynamic changes of systemic inflammatory markers and their association with radiologic progression and hepatotoxicity in patients with hepatocellular carcinoma on systemic therapy

Article

Last updated: 29 Mar 2025

Overview Similar Items

Article

Outcomes of hepatocellular carcinoma among patients receiving systemic therapy

Article

Pentraxin 3 level as a Biomarker for Diagnosis of Hepatitis C Virus Related Hepatocellular Carcinoma

Article

Impact of Prognostic Nutritional Index and Systemic Immune-Inflammation Index on the Clinical Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

Article

SERUM INTERLEUKIN-22 AS A MARKER OF DECOMPENSATED LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN CHRONIC HCV PATIENTS

Article

Changes in CD4 and CD8 after Interventional Management of Hepatocellular Carcinoma

Article

Can Serum Iron Parameters Represent Surrogate Markers for Chronic Hepatitis C-Based Hepatocellular Carcinoma?

Article

Factors affecting post-treatment outcomes in patients with hepatocellular carcinoma

Article

Evaluation of Tumor Necrosis Factor-α, Lactate Dehydrogenase and Gamma -Glutamyl Transferase as Independent Predictors for Monitoring Progressive HCV-Chronic Liver Disease

Article

Interleukin-27 levels and its Polymorphism in Hepatocellular carcinoma associated with Hepatitis C

Article

Plasma albumin m RNA as anon invasive Marker to predict liver injury in chronic Hepatitis C and Hepatocellular carcinoma patients